Earnings Labs

The Carlyle Group Inc. (CG)

Q4 2020 Earnings Call· Thu, Feb 4, 2021

$47.42

-0.63%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+1.39%

1 Week

+3.02%

1 Month

-0.58%

vs S&P

-0.84%

Transcript

Operator

Operator

Ladies and gentlemen, thank you for standing by and welcome the Carlyle Group Fourth Quarter 2020 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question and answer session. [Operator Instructions] I would now like to introduce your host for today, Mr. Daniel Harris, you may begin.

Daniel Harris

Analyst

Thank you, Kevin. Good morning, and welcome to Carlyle's fourth quarter and full year 2020 earnings call. With me on the call is our Chief Executive Officer, Kewsong Lee, and our Chief Financial Officer, Curt Buser. This call is being webcast and a replay will be available on our website. We will refer to certain non-GAAP financial measures during today's call. These measures should not be considered in isolation from or as a substitute for measures prepared in accordance with generally accepted accounting principles. We have provided reconciliations of these measures to GAAP in our earnings release. Any forward-looking statements made today do not guarantee future performance and undue reliance should not be placed on them. These statements are based on current management expectations and involve inherent risks and uncertainties, including those identified in the Risk Factors section of our Annual Report on Form 10-K that could cause actual results to differ materially from those indicated. Carlyle assumes no obligation to update any forward-looking statements at any time. Earlier this morning we issued a press release and a detailed earnings presentation, which is also available on our Investor Relations website. For the fourth quarter, we generated $145 million in fee-related earnings and $237 million in distributable earnings with DE per common share of $0.64. For the year FRE was $520 million and DE per common share was $2.05, both up from 2019 levels. We declared a quarterly dividend of $0.25 per common share. This quarter we are reporting our results under our new segment structure, which is more aligned with how we operate our business. All equity investment strategies are now captured in a single segment global private equity, that includes our former corporate private equity and real asset segments. All of our credit investment strategies remain in global credit and our investment solutions segment continues to house our portfolio management strategies As a reminder, we look forward to hosting our first Investor Day as a corporation on February 23 at 8:30 a.m. Registration is open and we do encourage you to pre-register if possible at ir.carlyle.com. At our upcoming Investor Day, our leadership team will discuss our corporate strategy and financial objectives as well as opportunities for each of our businesses. I'm sure many of your questions today could be tied to our longer-term outlook and topics we'd like to cover comprehensively at Investor Day and as such we may defer responding to these questions and address them at that time and in context with our broader plan. And with that, let me turn the call over to our Chief Executive Officer, Kewsong Lee.

Kewsong Lee

Analyst

Thank you, Dan. 2020 was a year of growth and positive change for Carlyle, despite the challenging and complex environment. Our focus in 2021 is to build on our current momentum, and we look forward to providing more detail on our strategy for accelerating growth at our Investor Day in two weeks. Today, I'd like to focus on three points. First Carlyle delivered very strong results for shareholders in 2020. Second, our investment portfolio is in great shape. And third, our business model and organization proved extremely resilient and adaptable to the changing environment. Let me start by focusing on our 2020 results, which were strong across all metrics. We generated a record $520 million in fee-related earnings, with margins in excess of 30%. The substantial progress from just a few short years ago when FRE was less than half of this year's level. Continuing to grow FRE remains a primary strategic focus. Distributable earnings increased 18% in 2020, and we expect continued growth in earnings as our investment portfolios perform and mature. Our investment activity picked up sharply throughout the year. Despite the challenging environment, we exited the year with great momentum deploying $9 billion of capital in the fourth quarter alone, and $18 billion for the year. Our ability to consistently deploy in good times and bad demonstrates the value of our global platform and multi-asset class approach. We also accelerated our exit pace, realizing $7 billion for our fund investors in the fourth quarter and $21 billion for the year. And since the beginning of 2020 we've taken eight of our portfolio companies public and have over $17 billion of current value in public securities that when realized will generate proceeds for our LPs and earnings for our shareholders. And the final highlight, we raised $27.5 billion…

Curt Buser

Analyst

Thank you, Kew, and good morning. We performed well in 2020 despite the pandemic and economic volatility throughout the year. We generated $762 million in distributable earnings, our best year since 2015 and DE per share of $2.05 for the year increased 20% over 2019. Before digging into our financial results, I'd like to touch on three items. First, our outlook for 2021 fee-related earnings and realized performance revenues. Second, the trajectory of our effective DE tax rate. And third, stock-based compensation expense and equity awards. First, fee-related earnings were $520 million in 2020 and excluding $30 million in cost recoveries during the first quarter adjusted FRE of $490 million, increased more than 8% year-over-year despite not raising new capital for any of our global private equity flagship funds. FRE margin on the adjusted basis was 30%, up nearly 200 basis points relative to 28% in 2019. For the year, global credit fee-related earnings of $99 million, more than doubled the 2019 level. While investment solutions FRE of $37 million was also more than double the prior year. In both cases, top line growth drove the majority of the year-over-year increase and margins expanded substantially in both segments. Looking at 2021, we expect realized performance revenues to continue to grow and we expect to produce similar to slightly higher FRE compared to adjusted 2020 results. Consolidated top line management fee revenues should modestly increase with more noticeable growth in investment solutions and global credit more than offsetting some downward fee pressure in global private equity as portfolio realizations increase. Global private equity will see growth in management fees and in FRE when our next multiyear fundraising cycle begins for our large flagship funds, which we do not expect to meaningfully affect our 2021 FRE results. Our net accrued carry of…

Kewsong Lee

Analyst

Thank you, Curt. We have worked hard over the past few years and our results this year reflect the momentum we have built. We're proud of the performance we delivered on behalf of our limited partners and our shareholders in 2020. And we are excited about the opportunities in front of us. We look forward to speaking with all of you in more detail on February 23rd. And let me now turn the call over to the operator to take your questions.

Operator

Operator

[Operator Instructions] Our first question comes from Craig Siegenthaler with Credit Suisse.

Craig Siegenthaler

Analyst

Thanks. Good Morning, Kew, Curt. Hope you are both doing well

Kewsong Lee

Analyst

Hey. Good morning.

Craig Siegenthaler

Analyst

So we wanted to start with the impressive fundraising results from the solutions business, which now almost has $60 billion of AUM. Could you provide us an update of how you view the addressable market, the competitive landscape and also the growth trajectory for your secondaries and co-investment businesses across both AlpInvest and Metropolitan

Curt Buser

Analyst

Craig, let me start. So in global credit, it was a very good year, nearly $10 billion of capital raised, good growth across the platform and it's really nicely disbursed in terms of the various components of the business and including even the CLO business. And in AlpInvest $14 billion of fundraising this year, a record year for fundraising, its AUM has been growing nicely. And the thing to also remember then in the case of AlpInvestis the burn off that we had in a lot of AUM in early years is really from some of the two major investors or shareholders in that business prior to our ownership. And so really the growth in AUM is even bigger than what you kind of see by looking at the aggregate numbers because you got to take into account that historical run-off. The team has really done a nice job of repositioning the industrial base across that whole platform and that secondaries program was $9 billion now in terms of the total program size, it didn't turn on fees really until the fourth quarter and so that should be a nice driver of fee revenue growth for that next year. And then as you think about the co-investment program, they're not just in raising their next kind of generation of that and that will be additive to next year as well; so really well-positioned for continued growth.

Kewsong Lee

Analyst

Hey, Craig, it's Kew. Taking a step back, if you think about it. Clearly, the private capital markets have really grown and are huge and so it shouldn't surprise all of us that large LPs and small LPs are a need of what I would call portfolio management solutions as they optimize risk and allocation to the asset class. And the way they do that is by first focusing on secondaries, second, trying to add co-investment opportunities, and third, obviously, in a diversified way they're looking for potentially ways to pick up interesting new GP commitments, but in a more diversified way. And AlpInvest is a platform that lets them do that. And so this whole area of alternatives I think is just going to continue to grow on the heels of the fact that the broader industry is growing. So that's a big picture number one. Number two, it used to be that these types of solutions were very bespoke in the past but, increasingly, we're seeing large carry over from our existing LP base as we try to minimize or add to deployment, manage risk, work on co-investment strategies, etcetera And so about 40% of the LPs in solutions I believe are also LPs in our existing global private equity and global credit franchise. So there is a huge cross-sell, but also an introduction to all of Carlyle, which solutions offers us to be able to introduce to our LP base. And then, finally -- and we're going to get into this in Investor Day, the performance of these strategies has been terrific and we're going to -- we'll show you more of that in two weeks, so please be patient. But that performance is the underlying driver for why we believe in these three very focused strategies, secondaries, co investments and primary fund to funds, we see real growth opportunity ahead of us in solutions.

Craig Siegenthaler

Analyst

Great. Kew, thank you for the comprehensive response

Kewsong Lee

Analyst

Thanks, Craig.

Operator

Operator

Our next question comes from Mike Carrier with Bank of America.

Dean Stephan

Analyst · Bank of America.

Hey, good morning. This is Dean Stephan on for Mike Carrier. Given the active deployment levels in the fourth quarter, can you just update us on the deployment outlook heading into '21, maybe what the pipeline is looking like and how quickly the $13 billion in pending fee earning AUM can potentially be invested or activated moving forward? Thanks.

Kewsong Lee

Analyst · Bank of America.

Hey, Dean, it's Kew here. I mean, look, we're about as busy as we've ever been, our pipelines are really full. And if there is one thing last year has taught all of us, it's that with change comes also lots of opportunity. Now the good news is our platform, be it regionally, be it different asset classes, be it different investment strategies, be it different investment sectors. We're well-positioned to go to where the opportunities are and be one step ahead. Valuation levels certainly very high, no doubt about it, but also the ability for us to add value, work with our teams to grow these businesses and help them, is also high. So that's the challenge, which is to keep finding these deals. And I think last year was a good indication of the way this platform can pivot, if there's volatility, we see opportunities in credit. If traditional buyouts get way too expensive, we see ways to grow in private equity growth investing, if certain western economy markets are a little bit more less active we saw a lots of activity in the Far East in India and in China. So our pipelines are very busy, valuation levels make it very difficult, but our platform is very well positioned I believe to keep finding great opportunities and create value.

Curt Buser

Analyst · Bank of America.

And just adding on the $13 billion -- a little over $13 billion of pending fee earning AUM is relatively evenly spread across the three segments, a little bit larger in global credit and investment solutions than in global private equity and a lot of that is really tied to as the funds either turn on as we complete fundraising or as we invest capital. And so both providing really good FRE ramps, particularly in global credit and investment solutions.

Dean Stephan

Analyst · Bank of America.

Got it. Thanks, guys.

Kewsong Lee

Analyst · Bank of America.

Thanks, Dean.

Operator

Operator

Our next question comes from Robert Lee with KBW.

Robert Lee

Analyst · KBW.

Great. Good morning, thanks for taking my question. I just wondered, maybe focus on the capital management a little bit. So just want to maybe refresh on, as you look forward particularly with realizations ramping, you have the stable quarterly dividend. So how should we think of dividend growth from here and where does -- how do you think of down the road buybacks versus reinvesting it in back in the business, and how do you think of that trade-off [ph]?

Curt Buser

Analyst · KBW.

Robert, hey, thank you for that question. Managing capital to really drive the business is obviously our core priority, making sure that that capital really is driving growth in earnings and growth in the business. And so making sure that we have capital to invest in our funds, new initiatives available for strategic growth initiatives, and then, etcetera is always a priority for us. But cornerstone to everything we do is making sure that we maintain our fixed dividend. And looking at how we will plan to grow that is we have indicated in the past is really as FRE grows, that's how we will grow our fixed dividend. So Yes, I would not expect anything near term because I already have indicated a kind of FRE will be similar to this past year, or slightly up, but when we are really kind of well-positioned for growth in FRE because that way we can underpin that six businesses what we want to do. With respect to dilution management, what we have said before is we want to be around 1% in terms of dilution. We're cautious with our use of capital and buybacks really in 2020 given the pandemic and all the related uncertainties. But you can see us kind of being active to think through how to make sure we manage that dilution both through equity grants as well as through buybacks.

Robert Lee

Analyst · KBW.

Great. Thank you.

Kewsong Lee

Analyst · KBW.

Thanks, Rob.

Operator

Operator

Our next question comes from Bill Katz with Citigroup.

Bill Katz

Analyst · Citigroup.

Okay. Thank you very much for taking the question, and good morning. So maybe one for Curt; could you sort of go back to your guidance on the realization outlook for 2021 and I just sort of wondering the jump off point, is it the full-year '20 as we look to 21? Is it the pacing for the fourth quarter and growing off there? And then, maybe the interplay of how that will tie to in terms of the comp ratio against those revenues? Thank you

Curt Buser

Analyst · Citigroup.

Bill, thanks for your question, and good morning. Yes, so as we talk about -- I presume you're talking about net realized performance revenues, so our net carry just to level set, we had $246 million of realized carry this past year, it was up about 50% from the prior year, but well below our average that we ran between 2012 to 2017 of over $600 million a year. We're clearly positioned to surpass $600 million, the wealthy [ph] accrued carry remaining fair value in the ground. But that's not going to occur in 2021 outlook. Capital markets could do something and we could exceed expectations to the high, but we could also miss and predicting carry is always really hard to predict with precision. What I said in my remarks in particular, was expect a gradual increase and things to watch is, so just in the past year, as we said Carlyle Partners VI turned on carry in Q3. We also said that we weren't taking carry at a full 20% rate, which was true through all of 202, we did not take carry on CP VI at the full rate. And if you look at where the fund is, it's nicely set up. So there is room to take it at a higher rate on CP VI going forward. More importantly though, there are many other funds that have not yet turned on carry that are in accrued carry. Asia buyout IV is a good example, Japan III is a good example. And so as those funds also get to positions where we're comfortable from a fallback management perspective and you know we're careful on that will signal to you as, as the bigger funds turn on, so that you will kind of know kind of what that trajectory is but that's also kind of thinking gradual increase does not all of that will hit on right away. Hopefully, that gives you some color, Bill.

Bill Katz

Analyst · Citigroup.

Okay. Thank you.

Operator

Operator

Our next question comes from Ken Worthington with JP Morgan.

Ken Worthington

Analyst · JP Morgan.

Hi, good morning. Turning to insurance; can you give us an update on Fortitude and maybe your priorities for your insurance operations? And then what are the next steps for insurance for Carlyle?

Kewsong Lee

Analyst · JP Morgan.

Hey, Ken, it's Kew. Let me give you a little bit of color as of the here and now. But I'd ask that everyone to be patient, because we will talk a bit more about this at our Investor Day. I mean, look, we're very pleased with our Fortitude is right now. Its adjusted book value is doing great, its annualized ROE right now is closer to the mid-teens and the liabilities are performing just in line with our expectations. It's got excess capital. More importantly, we have stood it up fully, it is carved out and it is ready to start scaling via reinsurance and/or acquisition. In terms of rotation, my understanding is of about $4.7 billion have already been rotated over to Carlyle in terms of assets under management, and this is on a track towards $6 billion, which we think will hit over the next year or so. Now, what's more important to understand is that rotation that's occurred is very broad across our platform. I think it's close to 25 funds have received the semi-permanent type of capital investment that Fortitude represents into our funds and it's across all three segments, global private equity, global credit and investment solutions. So the platform itself is very much on-track. We feel very good about it. And so the right question now is, okay, where do we go from here? And with respect to that, I'm going to ask that you be patient and wait because we want to talk about this a little bit more comprehensively at Investor Day in a couple of weeks.

Ken Worthington

Analyst · JP Morgan.

Great. Well, thank you very much.

Operator

Operator

Our next question comes from Michael Cyprys with Morgan Stanley.

Michael Cyprys

Analyst · Morgan Stanley.

Hey, good morning. Thanks for taking the question. Maybe just coming back to some of the commentary on your multi-year view on the carry sort of pick-up, if you will. I think if we look back at the 2011 to 2017 realization cycle, you guys seem to turn over the carry receivable balance of that every two years or so. So call it like a 50% pull-through or monetization of the receivable in a given year over that cycle. I guess is there anything different today with your fund line up and fund performance that could result, any different outcome than a 50% pull-through rate or so, as we look out over the next couple of years and what would you say are the top, if any limiting factors that would prevent you from hitting to say that 50% pull through that you've done in the past from hitting that over the next couple of years.

Curt Buser

Analyst · Morgan Stanley.

Mike, it's Curt. Really good analysis in terms of how to look at that and that's exactly right in terms of what happened back in 2012 to 2017 on average. But if you look at the past couple of years, that's not held through in the past couple of years. And a lot of that is making sure that the portfolio has been mature enough. And we're not yet at that place where it is fully mature to make that same kind of conclusion with respect to '21. I'll speak more to the outer years at our Investor Day in two weeks. But right now, I would be cautious about applying the same math to '21.

Michael Cyprys

Analyst · Morgan Stanley.

Is that math fair to apply to next couple of years beyond 2021 would you say or is there anything different with the portfolio today that could result in a different outcome than that sort of 50% roughly?

Curt Buser

Analyst · Morgan Stanley.

Yes. I think, you always have to be a little careful in that math only because a lot of it has to do with makeup at any point in time. And I would say it's more a correlation as opposed to causality but over long terms in good markets and capital markets are making sure that know all of the big buyout funds are producing carry, that's where it gets a little bit more comfortable.

Michael Cyprys

Analyst · Morgan Stanley.

Okay. Thank you.

Operator

Operator

Our next question comes from Gerry O'Hara with Jefferies.

Gerry O'Hara

Analyst

Great, thanks. Perhaps one just on global credit, fundraising obviously has been getting stronger and clearly momentum building in that segment. But perhaps you can give us a sense of what products are seeing the most traction and even what the pipeline for new solutions might look like. Thank you.

Kewsong Lee

Analyst

Sure, Gerry, it's Kew here. And I think you got [ph] to be bored of hearing this from me, this is one area, we're going to do a deep dive on in two weeks. The highlights though as we sit here today, you're right, there is great momentum in the global credit segment, it's a broad platform as you know. Our credit opportunity strategy is doing quite well. We're seeing, and all of you are seeing this, the CLO market is coming back, certainly, a pickup in activity level from last year and we are projecting to see continued strengthening in that market. With respect to some of the initiatives we have in the market today, I don't want to comment on them, because they are fundraising, but we do have global infrastructure credit for instance in the market raising funds. And this is a segment which is very scalable given what we have set up and we're also seeing real traction with respect to platform-wide special accounts and strategic accounts that can be on any one singular account quite large. So let me hold there and just say, we're pleased with the platform, the progress, the -- look, the dropdown in growth directly into earnings, but more to come in two weeks.

Gerry O'Hara

Analyst

Fair enough. Thanks for the thoughts.

Operator

Operator

Our next question comes from you Glenn Schorr with Evercore ISI.

Glenn Schorr

Analyst · Evercore ISI.

Hi, thanks. You kicked my interest a little bit. Curt, you mentioned when you're talking about the equity grants that there -- grants, it's obviously senior people and that's quite long-term milestones. Wonder if you could talk a little bit about the long-term milestones that they're tied to. I know they are aligned with the same things investors are looking for, but just any specifics there, I think people find interesting?

Curt Buser

Analyst · Evercore ISI.

Glenn, hey, thanks for your question. And as I said, these grants are mostly to the most senior people in the firm that can really kind of drive our FRE and our earnings results. They are largely -- or predominantly performance testing as opposed to time testing. There is a component of time, but it's mostly performance. And those milestones are really what underpins the strategic plan and a lot of that is FRE. And so as we grow FRE, you'll see vesting. And so we think that alignment is very good. Hopefully, that helps

Glenn Schorr

Analyst · Evercore ISI.

And the lumpiness -- Yes, definitely. I think the lumpiness or I should say, maybe even the stair-stepping historically of FRE is due to some of the big capital raises, has the growth in both global credit and investment solutions, is that enough to help smooth the cycle, if you will, or do we need to see more growth and say infrastructure retail, capital markets, the like. Is that even a goal to smooth that lumpiness?

Curt Buser

Analyst · Evercore ISI.

So well -- so -- for talking fee-related earnings, I think over the past three years, we've seen nice step up in fee-related earnings in each annual year and I would say over the last three years that lumpiness has not been that lumpy. For 2021, I've been very clear that you can expect similar FRE to 2020 as adjusted for that $30 million or slightly up. And that from a managed top line growth, again kind of similar, but you will see the more growth within the two segments of credit and solutions and some pressure on the fee side in global private equity, simply as its real -- its realizations we're expecting to be really good and so that will put some downward pressure. And then as they get back end from a fundraising perspective, that will bring back up management fees and FRE in that sector. But that's in later years. So again, stable to slightly up next year or this year 2021.

Glenn Schorr

Analyst · Evercore ISI.

Okay. See you on the 23rd for the rest. Thank you.

Curt Buser

Analyst · Evercore ISI.

Yes.

Operator

Operator

Our next question comes from Adam Beatty with UBS.

Adam Beatty

Analyst · UBS.

Hi, good morning, and thank you for taking the question. I want to circle back on the discussion around solutions from a competitive standpoint, not that competition there is new, but some of the standalone providers have recently gotten more attention from public offerings and such. So just wanted to see how Carlyle and AlpInvest are positively differentiated there and also you mentioned the interaction between solutions and the rest of Carlyle is that perceived by LPs as an advantage? Thank you.

Curt Buser

Analyst · UBS.

So let me start and then maybe Kew will jump in here. So the thing that I would point you to in terms of how we compete in the market for solutions and AlpInvest in particular. It's a long-standing business, great relationships with its respected GPs that invest with, but look at its track record. The performance in solutions and particularly and AlpInvest funds has been phenomenal. And I think that that really is a distinguishing factor in terms of how investors into that platform view us. And from a competitive standpoint, in terms of Carlyle, as well as the solutions platform, goes to market under a separate brand. We are very strong walls internally in terms of making sure that key information around their relationships are not reaching those walls, but the things from a fundraising perspective in terms of they want to make introductions and the like really helps build the platform using our distribution model to help them really bring around this very strong product set. So, hopefully that gets at most of your question.

Adam Beatty

Analyst · UBS.

Excellent. Thank you very much.

Kewsong Lee

Analyst · UBS.

Adam, the only thing I would add -- Yes, Adam, the only thing I would add is, first of all, from our LPs perspective, this is a complementary strategy, not a substitute of strategy. So they are squeezing [ph] AlpInvest as a way to further optimize allocation into private markets to further gain efficiency through co-invest, etcetera. So it's very much now in the discussion with our LPs with respect to adding on to their allocations to private capital and sitting side by side with Carlyle funds. So that's a huge advantage in the sense of -- it's now portfolio discussion and that's why I say the existing client base of Carlyle is going to be a huge advantage for us as we try to keep growing AlpInvest. Second of all, competition is good. It's going to create further growth in this market. And like I said, all of these strategies are going to benefit from the fact that there are trillions of dollars in private markets right now and these LPs are trying to figure out how to optimize allocation and risk into a private equity private credit strategy. So to a certain extent, healthy competition is a good thing. It's going to create more awareness and growth in this segment, which I think has got good tailwinds.

Adam Beatty

Analyst · UBS.

That's perfect, makes sense. Thank you.

Operator

Operator

And I'm not showing any further questions at this time. I'd like to turn the call back over to Daniel Harris.

Daniel Harris

Analyst

Thank you, Kevin. And thank you all for your time this morning and throughout the course of the past year. We are very much looking forward to speaking with all of you on our Investor Day on February 23rd. Any other questions you have today, please feel free to follow up with Investor Relations. We hope you have a great day.

Operator

Operator

Ladies and gentlemen, this does conclude today's presentation. You may now disconnect and have a wonderful day.